183 related articles for article (PubMed ID: 24924902)
1. A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma.
Li X; Dai D; Song X; Liu J; Zhu L; Xu W
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):583-91. PubMed ID: 24924902
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M
J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239
[TBL] [Abstract][Full Text] [Related]
3. [Cytokine-induced killer cells transfusion following minimally invasive and interventional therapy for early-stage hepatocellular carcinoma:a long-term study].
Dong A; Li W; Wu F; Huang Z; Xia J; Wu P
Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(33):2668-72. PubMed ID: 26711819
[TBL] [Abstract][Full Text] [Related]
4. [Value of CIK in the treatment of TACE combined with RFA for HCC in long-term survival and prognostic analysis].
Wang JP; Li W; Huang ZL; Wu PH; Li XS; Wei YD; Zhou QM; Pan CC; Xia JC; Zhao M
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3062-6. PubMed ID: 23328379
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
[TBL] [Abstract][Full Text] [Related]
7. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis.
He G; Zheng C; Huo H; Zhang H; Zhu Z; Li J; Zhang H
Int Immunopharmacol; 2016 Nov; 40():436-442. PubMed ID: 27716591
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative study.
Hao MZ; Lin HL; Chen Q; Ye YB; Chen QZ; Chen MS
Chin J Cancer; 2010 Feb; 29(2):172-7. PubMed ID: 20109346
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
12. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
Zhao M; Wu PH; Zeng YX; Xia JC; Zhang FJ; Xian LJ; Zhang YP; Zhou K; Fan WJ; Zhang L; Gao F; Zhou QM
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1823-8. PubMed ID: 17054858
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
Yi PS; Huang M; Zhang M; Xu L; Xu MQ
Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
[TBL] [Abstract][Full Text] [Related]
14. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
[TBL] [Abstract][Full Text] [Related]
16. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
[TBL] [Abstract][Full Text] [Related]
18. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.
Cheng BQ; Jia CQ; Liu CT; Fan W; Wang QL; Zhang ZL; Yi CH
JAMA; 2008 Apr; 299(14):1669-77. PubMed ID: 18398079
[TBL] [Abstract][Full Text] [Related]
19. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
[TBL] [Abstract][Full Text] [Related]
20. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
Zhou QM; Wu PH; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 Nov; 25(11):1414-8. PubMed ID: 17094912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
